~11 spots leftby Apr 2026

Repeatability and Reproducibility of the CADence™System

(SEQUEL Trial)

Recruiting at2 trial locations
RW
Overseen byROBERT WILSON, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: AUM Cardiovascular, Inc.
No Placebo Group

Trial Summary

What is the purpose of this trial?

This study is designed as a prospective study to capture data for evaluating the repeatability and reproducibility of the CADence™ System. The study will be conducted at 3 different study sites using 6 CADence™ systems. Each subject will be tested 4 separate times by 2 different operators at each site and will be tested at all 3 site locations in order to accomplish this evaluation. The study will enroll a total of at least 24 CADence positive patients and at least 24 CADence negative patients.

Research Team

RW

ROBERT WILSON, MD

Principal Investigator

University of Minnesota

Eligibility Criteria

Inclusion Criteria

Subjects clinically indicated for nuclear stress test and who satisfy all the inclusion

Treatment Details

Interventions

  • CADence™ System (Diagnostic Test)

Find a Clinic Near You

Who Is Running the Clinical Trial?

AUM Cardiovascular, Inc.

Lead Sponsor

Trials
4
Recruited
1,200+